Claire Conley, PhD, and Marcelo Sleiman, Jr., discuss the need for protocols in supporting patients’ psychosocial needs.
Treatment with systemic intravenous olvimulogene nanivacirepvec (Olvi-Vec) led to promising preliminary results in patients ...
The FDA has approved a monthly dosing schedule for subcutaneous amivantamab in NSCLC following the first 4 weeks of treatment ...
Clinical use cases include AI-assisted palliative-care triage, consolidating EHR signals to surface unmet supportive needs, and ambient listening that drafts notes for nurse verification and workload ...
The FDA has approved encorafenib plus cetuximab and fluorouracil-based chemotherapy in patients with BRAF V600E-positive metastatic colorectal cancer. The FDA has approved encorafenib (Braftovi) ...
The FDA has approved acalabrutinib plus venetoclax in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The FDA has approved the use of acalabrutinib (Calquence) tablets ...
Watch the latest shorts from Oncology Nursing News ...
Welcome to Onc Nurse On Call, the new podcast from Oncology Nursing News, hosted by editors-in-chief Patricia Jakel, MN, RN, AOCN, and Stephanie Desrosiers, DNP, MSN, RN, AOCNS, BMTCN, delivering ...
Recent regulatory actions from the FDA, including new drug application (NDA) acceptances and labeling updates, introduce new clinical considerations for oncology nurses and advanced practice providers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results